Abstract:BACKGROUND AND OBJECTIVES:Photodynamic therapy (PDT) has shown potentially beneficial results in treating port-wine stain, but its benefit-risk profile remains undefined. This study aimed to evaluate the efficacy and safety of PDT conducted with hemoporfin and a 532 nm continuous wave laser to treat port-wine stain clinically.PATIENTS AND METHODS:This randomized clinical trial was conducted in eight hospitals in China. Participants were adolescent and adult patients (age range: 14-65 years old) with port-wine stain. During stage 1 (day 1 to week 8) all patients were randomized at a 3:1 ratio to treatment (532 nm laser irradiation (96-120 J/cm2) with hemoporfin (5mg/kg; PDT-hemoporfin, n = 330)) or placebo groups (irradiation with placebo (PDT-placebo, n = 110)); during stage 2 (week 8 to 16) patients in both groups were offered treatment. Clinician-evaluators, who were blind to the study, classified each case on the following four-level scale according to assessment of before and after standardized pictures of the lesion area: no improvement: <20%; some improvement: 20-59%; great improvement: 60-89%; or nearly completely resolved: ≥90%. The primary efficacy endpoint was proportion of patients achieving at least some improvement at week 8. The secondary efficacy endpoints were proportion of patients achieving nearly completely resolved or at least great improvement at week 8, proportion of patients achieving early completely resolved, at least great improvement, or at least some improvement at week 16, and the corresponding satisfaction of the investigators and the patients (designated as 'excellent', 'good', 'moderate', or 'ineffective') at weeks 8 and 16.RESULTS:Compared to the PDT-placebo group, the PDT-hemoporfin group showed a significantly higher proportion of patients that achieved at least some improvement (89.7% [n = 295; 95% CI, 85.9%-92.5%] vs. 24.5% [n = 27; 95% CI, 17.4%-33.3%]) at week 8 (P < 0.0001) and higher improvements for all secondary efficacy endpoints. Treatment reactions occurred in 99.5% (n = 731; 95% CI, 98.7%-99.8%) of the PDT-hemoporfin treatments (n = 735). Hyperpigmentation occurred in 22.9 per 100 patient-treatments (n = 168; 95% CI, 20.0-26.0) in the PDT-hemoporfin treated patients.CONCLUSIONS:Hemoporfin-mediated PDT is an effective and safe treatment option for adolescent and adult patients with port-wine stain.TRIAL REGISTRATION:Chinese Clinical Trial Registry ChiCTR-TRC-08000213.

A first trial in the clinical application of photodynamic therapy for the prevention of restenosis after coronary-stent placement

Preventing intimal hyperplasia with photodynamic therapy using an intravascular probe

Clinical Efficacy of Drug Balloon Therapy for Patients with Coronary Artery In-Stent Restenosis with Unstable Angina Pectoris

Post-dilatation Improves Stent Apposition in Patients with ST-segment Elevation Myocardial Infarction Receiving Primary Percutaneous Intervention: A Multicenter, Randomized Controlled Trial Using Optical Coherence Tomography.

Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.

Clinical Significance of Optical Coherence Tomography–Guided Percutaneous Coronary Intervention for In‐Stent Restenosis Within Drug‐Eluting Stents: Impact on Patient Outcomes

Photodynamic effects on rabbit auricular veins after photosensitization with porfimer sodium: Implications of the results with respect to the treatment of esophageal varices with photodynamic therapy

A combination therapy of photodynamic therapy (PDT) and airway stent placement using a transparent silicone stent

Application of Photodynamic Therapy in Cardiology

Hemoporfin Photodynamic Therapy for Port Wine Stain: A Randomized Controlled Trial

Current Status of Photodynamic Therapy in Digestive Tract Carcinoma in Japan

The Short and Long Term Prognosis of Coronary Interventional the Rapy Assisted with Intracoronary Low Power Red Laser Irradiation

Clinical Impact of Perfusion Balloon for ST-segment Elevated Myocardial Infarction: RYUSEI Study

Photodynamic therapy of atherosclerosis using YAG-OPO laser and Porfimer sodium, and comparison with using argon-dye laser

Microneedle Patches with O-2 Propellant for Deeply and Fast Delivering Photosensitizers: Towards Improved Photodynamic Therapy

Basic and clinical research on photodynamic therapy at Tokyo Medical University Hospital

Clinical Practice of Photodynamic Therapy Using Talaporfin Sodium for Esophageal Cancer

Clinical trial of the CP stent for pulmonary artery stenosis: the first investigator-initiated clinical trial for pediatric interventional cardiology in Japan

Clinical effect of polymer-free sirolimus-eluting Nano stent on patients with coronary artery stenosis

Nine-month Angiographic and Two-Year Clinical Follow-Up of Polymer-Free Sirolimus-Eluting Stent Versus Durable-Polymer Sirolimus-Eluting Stent for Coronary Artery Disease: the Nano Randomized Trial.

Efficacy and Safety of Hemoporfin in Photodynamic Therapy for Port-Wine Stain: A Multicenter and Open-Labeled Phase Iia Study